Literature DB >> 24132552

The marginating-pulmonary immune compartment in mice exhibits increased NK cytotoxicity and unique cellular characteristics.

Marganit Benish1, Rivka Melamed, Ella Rosenne, Elad Neeman, Liat Sorski, Ben Levi, Lee Shaashua, Pini Matzner, Shamgar Ben-Eliyahu.   

Abstract

To test whether marginating-pulmonary (MP) leukocytes in mice have a unique potential to identify and destroy aberrant circulating cells, we compared MP to circulating leukocytes with respect to natural killer (NK) cytotoxicity, proinflammatory characteristics, molecular determinants of activation, and response to IL-12 immunostimulation. Cytotoxicity was assessed employing the YAC-1, B16F10, and 3LL target lines. C57BL/6 mice were injected with either saline or murine IL-12 (0.1 or 0.5 µg/mouse), either once or three times 48-h apart. Twenty-four hours after last injection, cardiac blood was withdrawn and MP leukocytes were collected by forced lung perfusion. NK cytotoxicity, cellular composition, and surface molecular markers were studied. MP leukocytes exhibited greater NK cytotoxicity than circulating leukocytes against the syngeneic B16F10 and 3LL tumor lines, but not against the allogeneic YAC-1 line. NKG2D and IL-12 receptor expression predicted NK cytotoxicity in circulating leukocytes, but not in MP leukocytes. IFNγ-receptor, IL-12-receptor, CD69, CD11a, and CD11b showed different patterns of expression in the two leukocyte populations, suggesting pro-inflammatory characteristics of the MP compartment. IL-12 stimulation caused differential effects on these markers and also elevated cytotoxicity in both compartments, but in different effector: target ratio-dependent patterns. MP leukocytes may play a critical role in eliminating aberrant circulating cells due to their enhanced NK cytotoxicity and given their strategic location in the lungs vasculature, which forces physical interactions with all circulating aberrant cells. MP-NK cells are unique in their cytotoxic mechanisms against syngeneic targets and in their activation profile and response to immunostimulatory agents.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24132552      PMCID: PMC5497121          DOI: 10.1007/s12026-013-8435-6

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  33 in total

1.  Recognition and prevention of tumor metastasis by the NK receptor NKp46/NCR1.

Authors:  Ariella Glasner; Hormas Ghadially; Chamutal Gur; Noa Stanietsky; Pinchas Tsukerman; Jonatan Enk; Ofer Mandelboim
Journal:  J Immunol       Date:  2012-02-03       Impact factor: 5.422

Review 2.  CD69 is an immunoregulatory molecule induced following activation.

Authors:  David Sancho; Manuel Gómez; Francisco Sánchez-Madrid
Journal:  Trends Immunol       Date:  2005-03       Impact factor: 16.687

3.  The pit cell: description of a new type of cell occurring in rat liver sinusoids and peripheral blood.

Authors:  E Wisse; J M van't Noordende; J van der Meulen; W T Daems
Journal:  Cell Tissue Res       Date:  1976-10-19       Impact factor: 5.249

4.  Adhesion mediated by LFA-1 is required for efficient IL-12-induced NK and NKT cell cytotoxicity.

Authors:  G Matsumoto; Y Omi; U Lee; T Nishimura; J Shindo; J M Penninger
Journal:  Eur J Immunol       Date:  2000-12       Impact factor: 5.532

5.  Involvement of LFA-1 in hepatic NK cell (pit cell)-mediated cytolysis and apoptosis of colon carcinoma cells.

Authors:  D Luo; D Vermijlen; K Vanderkerken; P J Kuppen; C Seynaeve; M Eddouks; M Baekeland; E Wisse
Journal:  J Hepatol       Date:  1999-07       Impact factor: 25.083

6.  Upregulation of IFN-gamma receptor expression by proinflammatory cytokines influences IDO activation in epithelial cells.

Authors:  Kari Ann Shirey; Joo-Yong Jung; Gregory S Maeder; Joseph M Carlin
Journal:  J Interferon Cytokine Res       Date:  2006-01       Impact factor: 2.607

7.  Essential role of LFA-1 in activating Th2-like responses by alpha-galactosylceramide-activated NKT cells.

Authors:  Goichi Matsumoto; Eiro Kubota; Yasushi Omi; Ushaku Lee; Josef M Penninger
Journal:  J Immunol       Date:  2004-10-15       Impact factor: 5.422

8.  Direct evidence for the role of LGL in the inhibition of experimental tumor metastases.

Authors:  T Barlozzari; J Leonhardt; R H Wiltrout; R B Herberman; C W Reynolds
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

9.  Increased susceptibility to metastasis during pro-oestrus/oestrus in rats: possible role of oestradiol and natural killer cells.

Authors:  S Ben-Eliyahu; G G Page; G Shakhar; A N Taylor
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

10.  Enhanced antitumor immunity in mice deficient in CD69.

Authors:  Enric Esplugues; David Sancho; Javier Vega-Ramos; Carlos Martínez; Uta Syrbe; Alf Hamann; Pablo Engel; Francisco Sánchez-Madrid; Pilar Lauzurica
Journal:  J Exp Med       Date:  2003-05-05       Impact factor: 14.307

View more
  6 in total

Review 1.  Perioperative events influence cancer recurrence risk after surgery.

Authors:  Jonathan G Hiller; Nicholas J Perry; George Poulogiannis; Bernhard Riedel; Erica K Sloan
Journal:  Nat Rev Clin Oncol       Date:  2017-12-28       Impact factor: 66.675

2.  The misleading nature of in vitro and ex vivo findings in studying the impact of stress hormones on NK cell cytotoxicity.

Authors:  Neta Gotlieb; Ella Rosenne; Pini Matzner; Lee Shaashua; Liat Sorski; Shamgar Ben-Eliyahu
Journal:  Brain Behav Immun       Date:  2014-12-26       Impact factor: 7.217

3.  PGE2 suppresses NK activity in vivo directly and through adrenal hormones: effects that cannot be reflected by ex vivo assessment of NK cytotoxicity.

Authors:  G Meron; Y Tishler; L Shaashua; E Rosenne; B Levi; R Melamed; N Gotlieb; P Matzner; L Sorski; S Ben-Eliyahu
Journal:  Brain Behav Immun       Date:  2012-11-12       Impact factor: 7.217

4.  Selective Harvesting of Marginating-hepatic Leukocytes.

Authors:  Liat Sorski; Lee Shaashua; Rivka Melamed; Pini Matzner; Shamgar Ben-Eliyahu
Journal:  J Vis Exp       Date:  2016-07-21       Impact factor: 1.355

5.  Selective Harvesting of Marginating-pulmonary Leukocytes.

Authors:  Lee Shaashua; Liat Sorski; Rivka Melamed; Shamgar Ben-Eliyahu
Journal:  J Vis Exp       Date:  2016-03-11       Impact factor: 1.355

Review 6.  Potential Use of Natural Killer Cell Transfer Therapy in the Perioperative Period to Improve Oncologic Outcomes.

Authors:  Juan P Cata; Claudius Conrad; Katy Rezvani
Journal:  Scientifica (Cairo)       Date:  2015-10-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.